Kevin Fischbeck
Stock Analyst at B of A Securities
(4.10)
# 502
Out of 4,944 analysts
173
Total ratings
68.03%
Success rate
5.89%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Neutral | $300 → $290 | $271.81 | +6.69% | 24 | Jul 30, 2025 | |
| ARDT Ardent Health | Downgrades: Underperform | $16 → $15 | $12.67 | +15.23% | 3 | Jul 16, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $27.07 | +10.82% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $178.51 | +3.64% | 15 | Jul 16, 2025 | |
| HCA HCA Healthcare | Downgrades: Neutral | $394 → $410 | $390.46 | +5.00% | 11 | Jul 16, 2025 | |
| HUM Humana | Maintains: Neutral | $320 → $260 | $281.99 | -7.80% | 15 | Jun 17, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $165 → $180 | $171.87 | +4.73% | 5 | May 14, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $20.77 | +114.30% | 6 | Feb 28, 2025 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $18.64 | +157.51% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $1.05 | +185.71% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $139 → $145 | $134.69 | +7.65% | 12 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $646 → $530 | $294.43 | +80.01% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $161.21 | +172.32% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.73 | -33.20% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $14.76 | -50.88% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $287.10 | +21.91% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $23.56 | +91.00% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $119.13 | -37.88% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $2.77 | +98.56% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $12.67 | +176.24% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.62 | +281.68% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $13.11 | -42.77% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $28.53 | -36.91% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $15.50 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $33.18 | -42.74% | 2 | Feb 9, 2018 |
UnitedHealth Group
Jul 30, 2025
Maintains: Neutral
Price Target: $300 → $290
Current: $271.81
Upside: +6.69%
Ardent Health
Jul 16, 2025
Downgrades: Underperform
Price Target: $16 → $15
Current: $12.67
Upside: +15.23%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $27.07
Upside: +10.82%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $178.51
Upside: +3.64%
HCA Healthcare
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $390.46
Upside: +5.00%
Humana
Jun 17, 2025
Maintains: Neutral
Price Target: $320 → $260
Current: $281.99
Upside: -7.80%
Tenet Healthcare
May 14, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $171.87
Upside: +4.73%
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $20.77
Upside: +114.30%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $18.64
Upside: +157.51%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $1.05
Upside: +185.71%
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $134.69
Upside: +7.65%
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $294.43
Upside: +80.01%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $161.21
Upside: +172.32%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.73
Upside: -33.20%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $14.76
Upside: -50.88%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $287.10
Upside: +21.91%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $23.56
Upside: +91.00%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $119.13
Upside: -37.88%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $2.77
Upside: +98.56%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $12.67
Upside: +176.24%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.62
Upside: +281.68%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $13.11
Upside: -42.77%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $28.53
Upside: -36.91%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $15.50
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $33.18
Upside: -42.74%